Legal Opinion

In re Generic Drug Pricing Antitrust Litigation

United States Judicial Panel on Multidistrict Litigation

Decided August 5, 2016No. MDL No. 2724PublishedCited by 2 opinions

1Opinion of the Court

TRANSFER ORDER

Before the Panel:* Plaintiffs in nine actions pending in the Eastern District of Pennsylvania move under 28 U.S.C, § 1407 to centralize pretrial proceedings in this litigation in the Eastern District of Pennsylvania. This litigation consists of the nine actions pending in the Eastern District of Pennsylvania and one action pending in the District of Rhode Island, as listed on Schedule A, The Panel also has been notified of seven related actions pending in the Eastern District of Pennsylvania.1

*1403All parties support centralization, but there is some disagreement as to the transferee…

2Cases cited1 opinion

  1. In re Skelaxin (Metaxalone) Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012

3Cited by2 opinions

  1. In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2018
  2. Molina Healthcare, Inc. v. Actavis Elizabeth, LLCDistrict Court, N.D. California · 2020

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API